Interv Cardiol Clin. 2024 Jul;13(3):421-430. doi: 10.1016/j.iccl.2024.02.002. Epub 2024 Mar 22.
ABSTRACT
Since PDA stenting was first attempted in the early 1990s, significant technical advancements have improved outcomes and some centers have even transitioned to exclusive PDA stenting for all infants with duct-dependent pulmonary circulation. In addition to its use in infants with duct-dependent pulmonary circulation, PDA stenting has also been adapted as a percutaneous palliative option for suprasystemic pulmonary arterial hypertension and as a component of the hybrid procedure. In this article, the authors aim to review indications and outcomes for PDA stenting, describe the procedure, and discuss future directions.
PMID:38839174 | DOI:10.1016/j.iccl.2024.02.002
